EMA 发布兽药 VGVP 医学重要 VeDDRA 术语清单指南草案并征求意见(EMA/CVMP/PhVWP/220641/2026)
Draft guideline on veterinary good pharmacovigilance practices (VGVP) - List of medically important (MI) VeDDRA terms
EMA 兽药委员会(CVMP)通过兽药良好药物警戒实践(VGVP)医学重要 VeDDRA 术语清单指南草案,于 2026 年 11 月 13 日启动公开征求意见,截止 2027 年 1 月 31 日。
PDF 文字版;图形和原始排版请参阅官方 PDF。
第 1 页
1 13 November 2026
2 EMA/CVMP/PhVWP/220641/2026
3 Committee for Veterinary Medicinal Products (CVMP)
4 Guideline on veterinary good pharmacovigilance practices
5 (VGVP) – List of medically important (MI) VeDDRA terms
6 Draft
7
Draft agreed by the PhVWP-V September 2026
Adopted by CVMP for release for consultation 05 November 2026
Start of public consultation 13 November 2026
End of consultation (deadline for comments) 31 January 2027
Agreed by <Working Party(ies)> <Month YYYY>
Adopted by CVMP <DD Month YYYY>
Date of coming into effect <DD Month YYYY>
8
9 This guideline replaces the Guideline on veterinary good pharmacovigilance practices (VGVP) Module:
10 Signal Management Appendix 1. Medically Important (MI) VeDDRA terms list (EMA/522332/2021).
11
Comments should be provided using this template. The completed comments form should be sent to
vet-guidelines@ema.europa.eu
12
Keywords Veterinary pharmacovigilance, VGVP, medically important terms, MIT, signal
management process, Union pharmacovigilance database
13
Official address Domenico Scarlattilaan 6 ● 1083 HS Amsterdam ● The Netherlands
Address for visits and deliveries Refer to www.ema.europa.eu/how-to-find-us
Send us a question Go to www.ema.europa.eu/contact Telephone +31 (0)88 781 6000 An agency of the European Union
© European Medicines Agency, 2026. Reproduction is authorised provided the source is acknowledged.
第 2 页
14 Guideline on veterinary good pharmacovigilance practices
15 (VGVP) – List of medically important terms (MIT)
16 Table of contents
17 1. Introduction ............................................................................................ 3
18 How to interpret and apply the MIT list in signal management: ......................................... 3
19 2. Medically Important Terms (MITs) .......................................................... 4
20
21
22
23
24
Guideline on veterinary good pharmacovigilance practices (VGVP) – List of medically
important terms (MIT)
EMA/CVMP/PhVWP/220641/2026 Page 2/12
第 3 页
25 1. Introduction
26 The MIT list comprises VeDDRA PTs that correspond to medical conditions which are commonly
27 involved in suspected adverse events across different pharmacological or therapeutic classes, or which
28 are considered medically important independently of any established causal association with a
29 veterinary medicinal product, due to their seriousness or potential impact on animal health or welfare,
30 public health, user safety or the environment.
31 The list of medically important terms has been previously an Appendix to the Guideline on veterinary
32 good pharmacovigilance practices (VGVP) Module: Signal Management (EMA/522332/2021) and has
33 now been separated in order to allow for more flexibility to update the list, as needed.
34 How to interpret and apply the MIT list in signal management:
35 Medically Important Terms (MITs) in veterinary pharmacovigilance are intended to function as a
36 prioritisation tool within signal detection and signal management activities. These events represent
37 medical concepts that require enhanced attention, prioritised assessment and timely regulatory follow-
38 up, in line with a proportionate pharmacovigilance approach.
39 In food-producing animals, MITs additionally include VeDDRA PTs that may be associated with
40 significant herd- or flock-level consequences (e.g. substantial productivity losses, reproductive
41 impairment, or increased mortality). Where such effects reflect or accompany medically important
42 safety concerns, they justify prioritisation within signal detection, validation and assessment activities.
43 For events occurring in humans, all reports are regarded as medically important and should therefore
44 be handled as MITs for the purposes of prioritisation and signal management, irrespective of the
45 reported clinical term, seriousness classification, or outcome.
46 All events that are reported as ‘parent-offspring’ events should be considered medically important and
47 particularly any congenital conditions reported in this setting.
48 Malignant neoplastic conditions and neoplastic conditions which otherwise have a serious impact on
49 animal health and welfare should be considered medically important on a case-by-case basis.
50 Detected signals involving MITs should generally be prioritised particularly in the following situations:
51 • Where they fulfil the criteria of a signal of disproportionate reporting (SDR) in DWH.
52 • Where an unusual or unexpected increase in reporting frequency or number of affected animals
53 is observed.
54 • Where there is evidence of increased severity or a change in outcome (compared to the
55 product information), such as an increase in fatal cases.
56
57
58
Guideline on veterinary good pharmacovigilance practices (VGVP) – List of medically
important terms (MIT)
EMA/CVMP/PhVWP/220641/2026 Page 3/12
第 4 页
59 2. Medically Important Terms (MITs)
60 Changes to the previous list are indicated in the last column, which will be removed in the final
61 version.
62 Abbreviation for changes: N: No changes compared to previous list; T: New MI term and species; S:
63 Changes to the species; D: Deleted.
Preferred Term (PT) MIT by Species Changes to
previous
list**
Abdominal pain Equine S
Abomasal perforation Camelid, Ruminant T
Abomasitis Camelid, Ruminant N
Abortion All N
Acidosis All T
Acromegaly Cat, Dog T
Acute mastitis All S
Adhesion in fish Fish T
Adrenal necrosis All T
Aggression - removed due to lack of specificity All D
Airsacculitis Bird T
Akinesia All T
Alkalosis All T
Anaphylaxis All N
Anorexia Cat, Equine, Rabbit, Rodent, S
Ruminant
Anuria All T
Any event Human N
Aplastic anaemia All T
Apnoea All N
Application site necrosis All T
Application site sarcoma All T
Arrhythmia All T
Asphyxia All T
Asystole All T
Guideline on veterinary good pharmacovigilance practices (VGVP) – List of medically
important terms (MIT)
EMA/CVMP/PhVWP/220641/2026 Page 4/12
第 5 页
Preferred Term (PT) MIT by Species Changes to
previous
list**
Ataxia All S
Autoimmune disorder NOS* All T
Arthritis All T
Bee systemic disorder NOS* Bee N
Birth defect – removed as it is covered by PT All D
Parent-offspring event
Blindness All N
Bone marrow hypoplasia All N
Bullous disorder All T
Bursa of Fabricius degeneration Bird T
Bursa of Fabricius lymphocyte depletion Bird T
Cachexia All T
Cardiac arrest All N
Cardiovascular embolism All T
Cardiac enlargement Cat, Dog, Equine T
Cardiac insufficiency All N
Cardiomyopathy All T
Carditis All T
Cerebral vascular accident All T
Cholangiohepatitis All T
Cholinergic disorder All T
Circulatory shock All N
Coagulopathy All N
Collapse NOS* All N
Coma All N
Convulsion – removed as covered by PT Seizure All D
Corneal perforation All T
Coronary artery disorder Cat, Dog, Equine T
Cyanosis All T
Deafness All N
Guideline on veterinary good pharmacovigilance practices (VGVP) – List of medically
important terms (MIT)
EMA/CVMP/PhVWP/220641/2026 Page 5/12
第 6 页
Preferred Term (PT) MIT by Species Changes to
previous
list**
Death All N
Developmental bone and joint disorders All T
Diabetes insipidus Cat, Dog, Equine T
Diabetes mellitus All N
Diabetic ketoacidosis Cat, Dog, Ferret T
Digestive tract haemorrhage NOS* All T
Digestive tract stenosis and obstruction NOS* All T
Disseminated intravascular coagulation All N
Dyspnoea All N
Dystocia All T
Egg drop Bird T
Egg peritonitis Bird T
Encephalitis All T
Encephalopathy NOS* All T
Endocarditis All T
Endotoxaemia All T
Enterotoxaemia All T
Environmental incident Not applicable T
Epileptic seizure – removed as covered by PT All D
Seizure
Eye paralysis All T
Fatty liver Cat T
Fish asphyxia Fish N
Fish body deformity Fish N
Foetal maceration All T
Foetal mummification All T
Foetal resorption All T
Gastric dilation Dog, Rabbit T
Gastric perforation All T
Gastric torsion Dog T
Guideline on veterinary good pharmacovigilance practices (VGVP) – List of medically
important terms (MIT)
EMA/CVMP/PhVWP/220641/2026 Page 6/12
第 7 页
Preferred Term (PT) MIT by Species Changes to
previous
list**
Gastrointestinal ulceration All T
Generalised skin reaction All T
Glaucoma All T
Goitre Cat, Equine T
Haematemesis All T
Haematochezia All T
Haemolytic anaemia All N
Haemophilia Dog T
Haemorrhagic diarrhoea All T
Haemorrhagic gastroenteritis All N
Head pressing All T
Heart block All N
Hepatic encephalopathy All T
Hepatic failure All N
Hepatic necrosis All T
Hepatic toxicosis All T
Hepatitis All T
Hepatopathy All T
Hyperadrenocorticism Cat, Dog, Equine T
Hyperparathyroidism All T
Hypersensitivity reaction All N
Hyperthyroidism Cat, Dog T
Hypoadrenocorticism Cat, Dog, Equine T
Hypocalcaemic condition All S
Hypoglycaemia All T
Hypomagnesaemic condition All S
Hypothyroidism Cat, Dog, Equine T
Hypoxia All T
Immune mediated encephalitis All T
Guideline on veterinary good pharmacovigilance practices (VGVP) – List of medically
important terms (MIT)
EMA/CVMP/PhVWP/220641/2026 Page 7/12
第 8 页
Preferred Term (PT) MIT by Species Changes to
previous
list**
Immune mediated haemolytic anaemia All T
Immune mediated meningitis All T
Immune mediated myelitis All T
Immune mediated polymyositis All T
Immune mediated thrombocytopenia All N
Immune-mediated polyarthropathy All T
Immune mediated glomerulonephritis All T
Impaired hearing All N
Impaired vision All N
Implant site necrosis All T
Implant site sarcoma All T
Increased blood urea nitrogen (BUN) or All T
creatinine
Increased coagulation time All N
Increased intracranial pressure All T
Infarction All T
Infertility NOS* All T
Inflammation of gill Fish T
Injection site necrosis All T
Injection site neoplasm NOS* All T
Injection site related amputation Cat, Dog T
Injection site sarcoma All T
Internal ear disorder All T
Intestinal perforation All T
Intestinal torsion All T
Intussusception All T
Jaundice All T
Keratoconjunctivitis sicca Cat, Dog, Equine T
Ketonuria Cat, Dog T
Ketosis All S
Guideline on veterinary good pharmacovigilance practices (VGVP) – List of medically
important terms (MIT)
EMA/CVMP/PhVWP/220641/2026 Page 8/12
第 9 页
Preferred Term (PT) MIT by Species Changes to
previous
list**
Lack of efficacy All T
Laminitis Equine S
Large intestine ulcer All T
Laryngeal spasm All T
Leukaemia All T
Leukopenia All T
Liver amyloidosis All T
Loss of appendage All T
Loss of consciousness All N
Lying down Camelid, Equine, Pig, Ruminant S
Medication error NOS* All T
Megaoesophagus Cat, Dog T
Melaena All T
Meningitis All T
Metastatic neoplasia All N
Methaemoglobinaemia All T
Metritis All S
Milk production decrease All T
Moribund All N
Mothering disorder All T
Multi-organ failure NOS* All N
Myasthenia gravis Cat, Dog, Equine T
Myelitis All T
Myelopathy All T
Myocarditis All T
Myoglobinuria Equine S
Myositis All T
Neonatal respiratory disorder All T
Nephritis All T
Guideline on veterinary good pharmacovigilance practices (VGVP) – List of medically
important terms (MIT)
EMA/CVMP/PhVWP/220641/2026 Page 9/12
第 10 页
Preferred Term (PT) MIT by Species Changes to
previous
list**
Nephropathy All T
Neurogenic keratoconjunctivitis sicca (KCS) All T
Oesophageal paralysis All T
Oesophagus perforation All T
Optic nerve disorder All T
Pancreatitis All T
Panleukopenia All T
Papillary necrosis All T
Paralysis All N
Paralytic ileus All T
Parent-offspring event All T
Paresis All N
Pemphigus All T
Pericardial effusion All T
Pericardial haemorrhage All T
Pericarditis All T
Perinatal mortality All N
Peripheral neuropathy All T
Peripheral vascular disorder All T
Peritonitis All T
Pinnal necrosis All T
Pneumonitis All T
Premature parturition All T
Pulmonary haemorrhage All T
Pulmonary oedema All T
Pulmonary stenosis All T
Pulmonary thromboembolism All T
Recumbency Camelid, Equine, Pig, Ruminant S
Renal amyloidosis All T
Guideline on veterinary good pharmacovigilance practices (VGVP) – List of medically
important terms (MIT)
EMA/CVMP/PhVWP/220641/2026 Page 10/12
第 11 页
Preferred Term (PT) MIT by Species Changes to
previous
list**
Renal insufficiency All N
Renal tubular disorder All T
Renal vascular disorder All T
Reticulitis Camelid, Ruminant N
Retinal detachment All T
Retinal haemorrhage All T
Ruminal bloat Camelid, Ruminant T
Ruminant stomach disorder Camelid, Ruminant T
Sarcoidosis Cat, Dog, Equine T
Seizure All T
Self mutilation All T
Septicaemia All T
Sinking, fish Fish T
Skin necrosis All T
Small intestine ulcer All T
Stillbirth All N
Suspected infectious agent transmission All N
Suspected recombination of a vaccine strain All T
Suspected reversal to virulence All T
Suspected transmission of a vaccine strain All T
Swim bladder disorder Fish T
Syncope All T
Systemic fungal infection All T
Tendon rupture All T
Tetany All T
Thrombocytopenia All N
Thrombosis All T
Thyroiditis Cat, Dog, Equine T
Tumour lysis syndrome All T
Guideline on veterinary good pharmacovigilance practices (VGVP) – List of medically
important terms (MIT)
EMA/CVMP/PhVWP/220641/2026 Page 11/12
第 12 页
Preferred Term (PT) MIT by Species Changes to
previous
list**
Uraemia All T
Uterine haemorrhage All T
Uveitis All T
Valvular disorder All T
Vasculitis All T
64
65 *NOS: Not otherwise specified.
66 ** T: New MI term and species.
67 S: Changes to the species.
68 N: No changes compared to previous list.
69 D: deleted.
70
Guideline on veterinary good pharmacovigilance practices (VGVP) – List of medically
important terms (MIT)
EMA/CVMP/PhVWP/220641/2026 Page 12/12
来源:EMA Scientific Guidelines · ema.europa.eu